Krishana Phoschem Ltd Q4 FY26 Earnings Analysis

- The new plant commissioning in April FY27 has capacity to add ~₹1,000 crores in revenue with an expected 60% utilization in the first year. - For FY26, Q4 revenue is expected to exceed the nine-month average of ~₹570 crores. - Manufacturing operations aim to maintain EBITDA margins of 14-15%, sometimes reaching 16%. - Trading (imports) revenue and volume will vary based on market demand and orders; currently, manufacturing is at full capacity. - Post current expansions, further growth plans will be evaluated based on market conditions and cash accruals, with no immediate CAPEX plans beyond March 2026. - The company targets sustainable volume growth supported by enhanced plant utilization beyond 100% and demand for varied fertilizer variants. - Management is focused on balancing capacity expansion with profitability and farmer affordability.

- The company expects continued robust growth driven by strong fertilizer demand, higher sales volumes, and improved plant utilization. - EBITDA margins for manufacturing are targeted to be maintained around 14-15%, sometimes reaching 16%. - The new plant commencing in April is expected to add nearly Rs. 1,000 crores in revenue at full capacity; first-year utilization target is ~60%. - Revenue for FY26 is expected to exceed the Rs. 570 crores average for the first nine months, indicating strong Q4 growth. - PAT and EPS have already shown significant YoY increases (PAT doubled to Rs. 97 crore; EPS to Rs. 15.7 for nine months) with further growth expected. - The Company aims to sustain profitability without aggressively raising prices despite cost pressures, leveraging operational efficiencies and government subsidies. - Expansion projects are on track for strengthening operating performance and long-term growth visibility.

- Current capex: Ongoing 50% expansion of NPK/DAP capacity at Meghnagar, including DAP, NPK, and sulfuric acid capacities; expected commissioning by March 2026. - Machinery orders placed, civil work nearly complete, trial production starting by March, commercial production from April 2026. - The new plant has a revenue potential of around Rs. 1,000 crore at full capacity; first-year utilization expected at ~60%. - No definite plans for capex beyond March 2026; future expansion contingent on successful completion of current projects and subsequent assessment of market conditions and cash accruals. - Company intends to fund expansions primarily through internal cash accruals. - Management is actively evaluating new strategic opportunities to diversify and scale integrated growth operations. - Shareholder approval for issuance of shared debentures is an enabling provision, but no immediate plans to raise capital this way.

- No immediate plans for new fundraising through debt or equity as the company's cash accruals and expansion plans are well synchronized. - Shareholder approval for issuance of share debentures exists as an enabling provision to avoid last-minute rush if capital is needed, but currently, there is no requirement for additional capital. - Future expansions beyond March 2026 will be funded primarily through internal cash profits, following past practices. - The company will evaluate further plans after successful implementation of the current plant and year-end financial results. - Listing on BSE is not currently under discussion, but the company may explore this possibility upon shareholder suggestion.

- The transcript does not explicitly mention the current or expected order book or pending orders in specific numbers. - It is noted that manufacturing is operating at almost 100% capacity and the company is importing to meet excess demand. - Future expansion projects, including the 50% expansion of NPK/DAP capacity at Meghnagar, are on track for commissioning by March 2026, indicating preparation for increased future orders. - Management will assess demand inflows and order variants after the new plant is commissioned to decide on adding new variants or geographical areas. - Trading/import volumes fluctuate based on market demand and orders from wholesalers and cooperative federations, making exact order book predictions difficult. - No concrete figures on outstanding orders were provided during the Q&A.